Operating Room Summit · May 2026
Summarizes Revolve’s table-mounted robot, outpatient-surgery focus, and early clinical deployment context.
Surgical robotics for every operating room
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Revolve Surgical is a Toronto-based medical robotics company building a table-mounted, zero-footprint surgical robot to make robot-assisted surgery accessible in smaller ORs, outpatient centers, and broader healthcare systems.
Primary product
Revolve Surgical System (RSS) / R1: a table-mounted, zero-footprint surgical robotics platform
Founded
2019
Headquarters
619-2 Carlton St, Toronto, ON M5B 1J3, Canada
Team size
1-10
Industry
Medical Equipment Manufacturing
Sub-industry
Surgical robotics / medical robotics
Offices
0 jobs at Revolve Surgical
Check back later for new openings
Business model
Stage
seed / accelerator-backed
Total raised
$125K
Latest round
Pre-Seed · Aug 2021
Latest amount
$125K
Jan 2026 · Healthcare Robotics Startup Catalyst
Apr 2024
Aug 2021 · Y Combinator
Aug 2021
Jun 2020
Leadership
Co-founder & COO; formerly CEO
Co-founder & CTO
Co-founder
Investors
Mission-driven and accessibility-focused, with an emphasis on making robotic surgery simpler, more affordable, and usable in a wider range of operating rooms.
Pricing
Contact sales / custom quote; positioned as comparable to laparoscopy
Differentiators
Technology
Customers
Competitors
Estimated revenue
<$5M (third-party estimate; public sources conflict)
Estimated monthly visits
2.9K
Traffic estimate as of Jul 2026
Operating Room Summit · May 2026
Summarizes Revolve’s table-mounted robot, outpatient-surgery focus, and early clinical deployment context.
MassDevice · Mar 2026
Reports FDA 510(k) clearance for Revolve Surgical’s table-mounted, zero-footprint platform; notes pilot studies and planned expanded clearance before commercial launch.
Becker's ASC · Mar 2026
Confirms FDA 510(k) clearance and describes the device as a zero-footprint, electromechanically controlled platform for minimally invasive abdominal surgery.
MassRobotics · Mar 2026
Industry write-up of Revolve’s FDA clearance, early adopter partnership, and goal of making surgical robotics more accessible.
ClinicalTrials.gov · Mar 2026
Unity Health Toronto registry entry for the first-in-human study using Revolve Surgical System (RSS) during appendectomy.